Global Phase III Clinical Trial - VIABLE

SOTIO is currently testing the safety and efficacy of SOTIO® DCVAC/PCa treatment in an extensive global multi-center Phase III clinical trial in prostate cancer called the VIABLE study, which was launched in 2014.

The VIABLE study recruited patients through cooperation with medical centers in 21 European countries and the United States. SOTIO enrolled a total of 1,182 prostate cancer patients in the study. The acronym VIABLE is derived from the description of this trial: actiVe ImmunotherApy using dendritic cell-Based treatment for Late stage prostatE cancer. For more information about the clinical trial please visit VIABLE Study website.

Description of Global Phase III - VIABLE clinical trial:

Clinical Trial SP005 VIABLE (Eudra CT: 2012-002814-38: IND: 015255) is a randomized, double-blind, multi-center parallel-group Phase III study designed to assess the efficacy and safety of DCVAC/PCa added to standard of care in comparison with placebo in men with metastatic castration-resistant prostate cancer eligible for first-line chemotherapy. For more information please visit www.clinicaltrials.gov.

Cookie name	Description	Expiration
BCAPPSESSID3	The BCAPPSESSID3 cookie is native to PHP and enables websites to store serialised state data. It is used to establish a user session and to pass state data via a temporary cookie, which is commonly referred to as a session cookie.	14 days
SSC_COOKIE_*	This cookie stores your decision regarding the storage of cookies in your browser.	2 years

Cookie name	Description	Expiration
_ga	The GA cookie is set, when a person visits your website for the first time. Google Analytics sends the client ID with each hit in order to associate hits with a user. A GA cookie can exist only on the device and browser where it has been set.	2 years
_gid	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing.	24 hours
_gat_gtag_UA_27872723_1	This cookie is used to throttle request rate. These are third party cookies that are placed on your device to allow us to use the Google Analytics service. These cookies are used to collect information about how visitors use our website. We use this information to compile reports and to help us improve the website.	Immediately
AW_VISITOR	Performance cookie to analyze traffic.	1 year

Global Phase III Clinical Trial - VIABLE

Description of Global Phase III - VIABLE clinical trial:

Your privacy

Strictly necessary cookies

Performance cookies

Functional cookies

Targeting and Advertising cookies

More information about Cookies